Edwards pushes CMS to expand Medicare TAVR coverage as agency opens public comment period through January 2026 for decision.

These were among our most popular Trivia Tuesday articles this past year. Amanda Pedersen is a veteran journalist and ...

David Fischel, Stereotaxis CEO, talks about the market opportunity for the company’s surgical robotic solutions.

This week in Pedersen’s POV, MD+DI Senior Editor Amanda Pedersen explores the potential over-reliance on a medical device ...

Comparative trials are among the hardest studies to execute in medtech, especially when the control arm is a long-established standard of care. Arun Menawat, CEO of Profound Medical, understands how ...

Philips acquires SpectraWave as medtech deals increase in December, with AI-powered coronary imaging technology boosting portfolio.

The medtech job market faces major shifts in 2026 due to federal layoffs, AI adoption, and M&A activity. Versatile skills ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Ajinomoto launches CELLiST AAV Production Supplement 1, boosting gene therapy viral vector productivity by 1.3-2x.

Building FDA submissions like a solid house requires early collaboration, proactive planning, and a clear regulatory story.

Peijia's TaurusTrio TAV system wins NMPA approval, revolutionizing severe AR treatment with Jenavalve's locator technology.

CMS AI Playbook v4 mandates prompt safeguards and auditable data lineage for generative AI in hospitals. Non-compliance risks ...